Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × oprelvekin × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Carboplatin 99 Cisplatin 97 pembrolizumab 90 Gemcitabine 82 Paclitaxel 79 Docetaxel 71 Capecitabine 58 Oxaliplatin 53 Fluorouracil 52 Specimen Handling 51 Bevacizumab 51 Radiotherapy 50 Magnetic Resonance Spectroscopy 48 Dexamethasone 44 Cyclophosphamide 43 Leucovorin 40 Pemetrexed 39 Drug Therapy 39 Irinotecan 38 Doxorubicin 37 Injections 31 Rituximab 29 Vincristine 26 Trastuzumab 26 Lenalidomide 26 Etoposide 26 Radiosurgery 25 130-nm albumin-bound paclitaxel 25 Radiation 24 Prednisone 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡